The full IPO calendar is available at IPOpremium. The scheduled IPOs are ranked by IPO size.
(1) Based in Mountain View, CA, Coupons.com (COUP) scheduled a $130 million IPO on the NYSE with a market capitalization of $945 million at a price range midpoint of $13 for Friday, March 7, 2014.
COUP operates a leading digital promotion platform that connects great brands and retailers with consumers.
(2) Based in Menlo Park, CA, TriplePoint Venture Growth BDC (TPVG) scheduled a $125 million IPO on the NYSE with a market capitalization of $129 million at a price range midpoint of $15 for Thursday, March 6, 2014.
TPVG is a business development corp (BDC) that focuses on venture growth stage companies in technology, life sciences and other high growth industries.
(3) Based in Vancouver, Canada, Aquinox Pharmaceuticals (AQXP) scheduled a $41 million IPO on the Nasdaq with a market capitalization of $107 million at a price range midpoint of $11 for Friday, March 7, 2014.
AQXP is a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation and cancer.
(4) Based in Malvern, PA, Recro Pharma (REPH) scheduled a $28 million IPO on the Nasdaq with a market capitalization of $59.2 million at a price range midpoint of $11 for Friday, March 7, 2014.
REPH is a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, initially in the post-operative setting.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer